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MaOBJECTIVES The aim of this study was to investigate gender-based differences in nuclear cardiology practice globally,
with a particular focus on laboratory volume, radiation dose, protocols, and best practices.
BACKGROUND It is unclear whether gender-based differences exist in radiation exposure for nuclear cardiology
procedures.
METHODS In a large, multicenter, observational, cross-sectional study encompassing 7,911 patients in 65 countries,
radiation effective dose was estimated for each examination. Patient-level best practices relating to radiation exposure
were compared between genders. Analysis of covariance was used to determine any difference in radiation exposure
according to gender, region, and the interaction between gender and region. Linear, logistic, and hierarchical regression
models were developed to evaluate gender-based differences in radiation exposure and laboratory adherence to best
practices. The study also included the United Nations Gender Inequality Index and Human Development Index as cova-
riates in multivariable models.
RESULTS The proportion of myocardial perfusion imaging studies performed in women varied among countries; how-
ever, there was no significant correlation with the Gender Inequality Index. Globally, mean effective dose for nuclear
cardiology procedures was only slightly lower in women (9.6  4.5 mSv) than in men (10.3  4.5 mSv; p < 0.001), with a
difference of only 0.3 mSv in a multivariable model adjusting for patients’ age and weight. Stress-only imaging was
performed more frequently in women (12.5% vs. 8.4%; p < 0.001); however, camera-based dose reduction strategies
were used less frequently in women (58.6% vs. 65.5%; p < 0.001).
CONCLUSIONS Despite significant worldwide variation in best practice use and radiation doses from nuclear cardiology
procedures, only small differences were observed between genders worldwide. Regional variations noted in myocardial
perfusion imaging use and radiation dose offer potential opportunities to address gender-related differences in delivery of
nuclear cardiology care. (J AmColl Cardiol Img 2016;9:376–84)©2016 by the American College of Cardiology Foundation.m the aCollege of Physicians and Surgeons, Columbia University, New York, New York; bDivision of Cardiology, Department of
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AB BR EV I A T I O N S
AND ACRONYM S
CAD = coronary artery disease
GII = Gender Inequality Index
HDI = Human Development
Index
MPI = myocardial perfusion
imaging
PET = positron emission
tomography
SPECT = single-photon
emission computed
tomography
99mTc = technetium-99m
201 = thallium-201
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377T here are fundamental differences in the path-ophysiology, risk factors, and clinical presen-tation of coronary artery disease (CAD) in
women compared with men (1). Indeed, women are
more likely to have angina from coronary microvas-
cular dysfunction, whereas men are more likely to
have angina from epicardial CAD (2). Women are
more likely to be susceptible to psychosocial risk fac-
tors thanmen (3). Further, medical tests used to detect
CAD may have limitations associated with sex. For
example, the sensitivity and specificity of an exercise
test are lower in women than in men (4–6), although
the addition of myocardial perfusion imaging (MPI)
with single-photon emission computed tomography
(SPECT) can improve the diagnostic performance of
exercise testing regardless of a patient’s sex (4–6).
With SPECT MPI, breast attenuation artifact is often
increased in women compared with men, whereas
spatial resolution is decreased (7). Because positron
emission tomography (PET) uses attenuation correc-
tion routinely and provides higher spatial resolution
and lower radiation dose compared with SPECT, it
may be preferable to use PET in women who need
MPI (8). PET MPI, however, is more expensive and
much less available compared with SPECT. Regardless
of whether SPECT or PET is used, the benefits of MPI
in the diagnosis and risk assessment (9) of CAD are
unequivocal in both women and men (7,10–12).SEE PAGE 385Controversy exists, however, regarding the long-
term health consequences after exposure to ionizing
radiation for MPI and medical imaging (13), particu-
larly in women (14,15). An Institute of Medicine report
identified ionizing radiation from computed tomog-
raphy (CT) as a contributing factor for breast cancer in
women (15). Similarly, a higher hazard of radiation-
related solid cancer has been estimated in women
compared with men (16). Such concerns of greater
radiosensitivity in women have the potential to affect
patterns of use differentially, in particular radiation
dose reduction protocols for diagnostic testing, in
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well as gender differences between women
and men that may affect MPI, several ques-
tions arise: What is the current proportion of
women compared with men undergoing MPI?
Are there differences in the way these studies
are performed from a global perspective? Does
the broader context of social, environmental,
and community factors play a role in best
practices? Are women more likely to have PET
rather than SPECT? To date, gender-based
patterns of radiation exposure across nuclear
cardiology laboratories have been unknown.
Accordingly, in this report, we compared the
rates of radiation exposure in women to men
through a multinational observational cross-sectional
study, INCAPS (International Atomic Energy Agency
Nuclear Cardiology Protocols Study), which examined
worldwide nuclear cardiology practices (17). The pur-
pose of this report is to determine whether differences
in radiation dose from MPI exist between women and
men and to examine the use of radiation dose reduc-
tion practices in women compared withmen in diverse
societies across the spectrum of gender equality and
human development status.
METHODS
Details of INCAPS have been previously reported (17).
In brief, INCAPS was an observational cross-sectional
study of protocols used for each of the 7,911 MPI
studies performed in 308 participating laboratories in
65 countries (Figure 1) during a single week in March or
April 2013. A waiver for Institutional Review Board
approval was provided by the Institutional Review
Board at Columbia University Medical Center (New
York, New York), where all data analysis was
conducted.
DATA COLLECTED. Anonymized patient-specific data
including gender, age, body weight, scanner, and MPI
protocol used were collected from diverse regions of
the world including Africa (n ¼ 348), Asia (n ¼ 1,469),
Europe (n ¼ 2,381), Latin America (n ¼ 1,139), North
America (n ¼ 2,135), and Oceania (n ¼ 439). Protocol
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FIGURE 1 Proportion of Women Receiving MPI by Participating Country in INCAPS
Countries that contributed <10 patients in INCAPS are not depicted in this figure. MPI ¼ myocardial perfusion imaging.
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378details obtained included modality (SPECT or PET),
1-day versus 2-day study, imaging position, use of
attenuation correction (CT or radionuclide), and the
type and dose of radiopharmaceutical used. The whole
body effective dose for each subject in this study was
estimated on the basis of the type and dose of radio-
pharmaceutical used, as described previously (17).
In addition to patient-level and institutional-level
analyses, regional analyses were performed at the
level of the geographic regions. Geographic regions
were defined as Africa, Asia, Europe, Latin America
(including Mexico, Central, and South America), North
America (Canada and the United States), and Oceania
(Australia and New Zealand).
OUTCOME VARIABLES. The primary outcome vari-
able for this study was the estimated whole body
effective dose. The secondary outcome variables were
as follows: the use of various types of protocols (e.g.,
1-day vs. multiday, PET vs. SPECT, as well as different
radiopharmaceuticals); the use of laboratory best
practices to optimize MPI radiation dose; and labo-
ratory procedure volumes. Of 8 laboratory best prac-
tices pre-specified by an International Atomic Energy
Agency expert committee (17), in this study we
focused on 4 practices that could be interpreted on a
per-patient basis: 1) avoidance of dual-isotope stresstesting in patients #70 years of age; 2) avoidance
of thallium-201 (201Tl) stress testing in patients
#70 years of age; 3) use of stress-only imaging when
appropriate; and 4) use of camera-based dose reduc-
tion techniques. The use of camera-based dose
reduction techniques was defined as at least 1 of the
following: 1) attenuation correction (CT or line
source); 2) multiple position imaging (e.g., supine and
prone); 3) high-technology software (e.g., incorpo-
rating resolution recovery or noise reduction, or
both); and 4) high-technology hardware (e.g., PET or
solid-state SPECT cameras).
SOCIETAL AND ECONOMIC FACTORS. We consid-
ered two global societal metrics that have the potential
to affect gender differences in the practice of nuclear
cardiology: the Gender Inequality Index (GII) (18) and
the Human Development Index (HDI) (19), both pub-
lished annually by the United Nations Development
Program. We used the 2013 versions of GII and HDI.
Gender inequality in a country was quantified using
the GII, a composite index reflecting gender in-
equalities in reproductive health, empowerment, and
economic status, which incorporates diverse data
from the United Nations, its agencies such as UNESCO,
and related organizations such as the Inter-
Parliamentary Union. Designed to measure the
TABLE 1 Representation of Women and Men by Worldwide
Region in This Study
Women
(n ¼ 3,254)
Men
(n ¼ 4,657) p Value
Age, yrs 65.1  12.0* 63.5  12.0 <0.001
Weight, kg† 74.3  18.0 84.4  18.1 <0.001
Regions 0.005
Africa 39% 61%
Asia 38% 62%
Europe 40% 60%
Latin America 43% 57%
North America 43% 57%
Oceania 45% 55%
Total effective
dose for MPI #9 mSv
42.1% 36.4% <0.001
Effective dose, mean 9.6  4.5 10.3  4.5 <0.001
Effective dose, median 9.8 10.4 0.001
Effective dose, IQR 5.8–12.5 7.5–12.8 —
Radiopharmaceuticals used
Technetium-99m 90.8% 90.2% 0.34
Thallium-201 4.6% 6.6% <0.001
Rubidium-82 5.4% 4.8% 0.20
Nitrogen-13 ammonia 0.7% 0.5% 0.22
Fluorine-18
fluorodeoxyglucose
0.3% 0.7% 0.02
Values are mean  SD, %, median, or IQR. *p < 0.0001. †Weights were not
available for 83 patients (47 male, 36 female), all in a single laboratory.
IQR ¼ interquartile range; MPI ¼ myocardial perfusion imaging.
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379human development costs of gender inequality, a high
GII reflects more disparities between the sexes and
more loss to human development. A country’s human
development was quantified using the HDI, a sum-
mary measure, that takes into account average
achievement in key areas of human development,
including life expectancy, education, and standard of
living. A high HDI reflects a high level of human
development. Details as to how GII (18) and HDI (19)
are calculated can be found in the statistical annex to
the United Nations Development Program’s report
“Human Development Report 2015: Work for Human
Development” (20).
STATISTICAL ANALYSES. Descriptive statistics were
calculated for the outcome variables and were
compared between men and women. Continuous
variables were described in terms of mean  SD and
median (interquartile range), and were compared us-
ing Student t tests and Kruskal-Wallis tests, respec-
tively. Categorical variables were compared using
chi-square tests. Correlation was evaluated using the
Pearson correlation coefficient. A p value <0.05 was
considered statistically significant.
Comparisonswere performed at theworld, regional,
and country levels, where appropriate. In addition,
regression models (linear, logistic, and hierarchical)
were developed to determine whether gender was
associated with outcome variables. Analysis of
covariance was used to ascertain whether a difference
in dose according to gender or region existed and to
evaluate the interaction between gender and region,
with weight included in the model as a continuous
variable, to adjust for potential between-group dif-
ferences in patients’ weight. Furthermore, the rela-
tionship between GII and HDI, and best practices, were
explored using logistic regressionmodels. All analyses
were performed using Stata/SE version 13.1 (StataCorp,
College Station, Texas) software.
RESULTS
BASELINE CHARACTERISTICS. Of the 7,911 patients
in this study, 41% were women. Depending on the
region of the world, women represented 38% to 45%
of all patients undergoing MPI. The proportion of
women in each of the countries that participated in
INCAPS is illustrated in Figure 1. There was no sig-
nificant correlation between GII and the countrywide
proportion of MPIs performed on women (r ¼ 0.15;
p ¼ 0.32). Women were on average older (mean age
65.1  12.0 years vs. 63.5  12.0 years; p < 0.0001) and
lighter (74.3  18.0 kg vs. 84.4  18.1 kg; p < 0.0001)
when compared with men. Women received a lower
effective dose (mean effective dose 9.6  4.5 mSv vs.10.3  4.5 mSv; p < 0.0001) for nuclear cardiology
studies when compared with men (Table 1). After
using a hierarchical linear regression model to
adjust for weight and age, female gender still
remained a significant predictor of lower effective
dose (Table 2, Simple Model), with a 0.3 mSv lower
effective dose in women (beta: 0.305; 95% confi-
dence interval: 0.430 to 0.179; p < 0.001).
GENDER-SPECIFIC EFFECTIVE DOSE PATTERNS
ACROSS THE GLOBE. The effective dose of MPI in
women relative to men varied by country (Figure 2)
and by geographic region (Figure 3). The mean effec-
tive dose for women versus men in Africa was 9.0 
5.5 mSv versus 10.2  5.5 mSv; in Asia it was 10.9 
4.8 mSv versus 11.8  4.8 mSv; in Europe it was
7.3  3.5 mSv versus 8.3  3.4 mSv; in Latin America it
was 11.4  4.3 mSv versus 12.0  4.0 mSv; in North
America it was 10.3  4.5 mSv versus 10.6  4.6 mSv;
and in Oceania it was 9.1  3.8 mSv versus 9.4  3.6
mSv. Analysis of covariance adjusting for weight
demonstrated a statistically significant difference in
the mean effective dose according to gender that
varied by geographic region (main effect for region:
degrees of freedom 5 and 7,815, F statistic 206.1, p <
0.001; main effect for gender: degrees of freedom 1
and 7,815, F statistic 7.89, p ¼ 0.005; and an interac-
tion between gender and region: degrees of freedom
TABLE 2 Impact of Gender on Patient Effective Dose From MPI: Hierarchical Regression Models*
Factors
Simple Model (Adjusts for Weight and Age)
Comprehensive Model
(Adds Protocols and Best Practices)
Predicted Difference in ED
(mSv) (95% CI) p Value
Predicted Difference in ED
(mSv) (95% CI) p Value
Female 0.303 (0.429 to 0.178) <0.001 0.055 (0.150 to 0.040) 0.26
Weight, per kg 0.035 (0.032 to 0.039) <0.001 0.035 (0.033 to 0.038) <0.001
Age, per yr 0.004 (0.001 to 0.009) 0.013 0.005 (0.001 to 0.009) 0.02
1-day SPECT — — 5.721 (5.420 to 6.022) <0.001
Multiday SPECT — — 6.744 (6.418 to 7.071) <0.001
Avoid dual isotope — — 3.490 (4.042 to 2.938) <0.001
Avoid stress thallium — — 3.825 (4.215 to 3.436) <0.001
Stress-only protocol — — 5.079 (5.279 to 4.878) <0.001
Camera-based dose
reduction technique(s)
— — 0.757 (1.005 to 0.509) <0.001
Intercept 7.710 (7.070 to 8.352) <0.001 9.760 (8.863 to 10.658) <0.001
*In Comprehensive Model, Stata omitted positron emission tomography and assigned a coefficient of 0, as it shows high collinearity with other variables. The between-gender
difference in ED after adjusting for age and weight is a modest 0.3 mSv (Simple Model), which is statistically significant. This difference appears to be related to a difference in
use of protocols and best practices because after correction for these (Comprehensive Model) the negligible difference of 0.05 mSv is not statistically significant.
CI ¼ confidence interval; ED ¼ effective dose; SPECT ¼ single photon emission computed tomography.
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3805 and 7,815, F statistic 3.24, p ¼ 0.006). Equality be-
tween the sexes was seen only in North America and
Oceania; elsewhere, women received a slightly lower
effective dose associated with MPI than did men, and
this difference was most pronounced in Europe.tion of the Relative Mean Effective Radiation Dose for Women Compared
ibuted <10 patients in INCAPS are not depicted in this figure.IMPACT OF MPI PROTOCOLS AND BEST PRACTICES ON
EFFECTIVE DOSE AMONG MEN AND WOMEN. The fre-
quency of different patient-specific MPI protocols and
estimated effective dose stratified by gender is shown
in Table 3. Stress-only imaging was more frequentWith Men in Each of the Countries That Participated in INCAPS
FIGURE 3 Effective Dose From MPI by Geographic Region Stratified by Gender
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Box and whisker plots illustrating the median effective dose for women and men in each of
the 6 regions studied. Women received a very modestly lower median effective dose for
myocardial perfusion imaging (MPI) compared to men in all regions. The median effective
dose for women versusmen in Africa was 8.6 versus 9.4mSv (p¼0.05, Kruskal-Wallis test);
in Asia was 11.2 versus 11.5mSv (p¼0.002); in Europewas 7.3 versus 8.7mSv (p<0.001); in
Latin America was 12.1 versus 12.2mSv (p¼0.07); in North America was 11.3 versus 11.4mSv
(p¼ 0.05); and in Oceania was 10.1 versus 10.2 mSv (p¼ 0.61). The mean effective dose for
women versusmen in Africa was 9.0 5.5 versus 10.2 5.5mSv (p¼0.035, Student t test);
in Asia was 10.9  4.8 versus 11.8  4.8 mSv (p ¼ 0.001); in Europe was 7.3  3.5 versus
8.3 3.4mSv (p<0.001); in Latin America was 11.44.3 versus 12.04.0mSv (p¼0.02);
in North America was 10.3 4.5 versus 10.6 4.6mSv (p¼0.08); and in Oceania was 9.1
3.8 versus 9.4  3.6 mSv (p ¼ 0.35). F ¼ female; M ¼ male.
TABLE 3 Between-Gender Differences in Frequency and Effective Dose of Specific MPI
Protocols and Best Practices
Frequency (%) Effective Dose (mSv)
Women
(n ¼ 3,254)
Men
(n ¼ 4,657) p Value Women Men p Value
Basic protocols
1-day SPECT 2,262 (69.5) 3,225 (69.3) 0.80 9.5  4.4 10.3  4.3 <0.001
Multiday SPECT 786 (24.2) 1,164 (25.0) 0.39 11.4  3.9 11.5  3.9 0.52
PET 206 (6.3) 268 (5.8) 0.29 3.4  1.8 4.0  2.9 0.005
Best practices
Avoid dual isotope* 3,222 (99.0) 4,588 (98.5) 0.05 21.6  1.8 20.5  3.5 0.10
Avoid stress thallium* 3,197 (98.2) 4,540 (97.5) 0.02 15.4  3.3 15.6  3.4 0.73
Stress-only 408 (12.5) 392 (8.4) <0.001 3.8  1.7 4.2  2.0 <0.001
Camera-based
dose reduction
1,820 (55.9) 2,948 (63.3) <0.001 8.6  4.4 9.4  4.3 <0.001
Values are n (%) or mean  SD. *Doses listed are those for dual-isotope and stress thallium imaging.
PET ¼ positron emission tomography; SPECT ¼ single-photon emission computed tomography.
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381in women compared with men (12.5% vs. 8.4%;
p < 0.001). Indeed, stress-only imaging occurred in
23.0% of women who underwent MPI in Europe,
as compared with only 14.2% of men (p < 0.001).
Dual-isotope imaging was less frequent in women
compared with men (1.0% vs. 1.5%; p < 0.001). In
women, the mean effective dose ranged from 3.4 mSv
for PET to 21.6 mSv for dual-isotope procedures. For
men, the mean effective dose ranged from 4.0 mSv
for PET to 20.5 mSv for dual-isotope procedures.
Multiposition imaging (supine and prone or supine
and upright) was more commonly used on men
compared with women (9.7% vs. 3.9 %; p < 0.001).
Even after excluding multiposition imaging, camera-
based dose reduction methods remained more
frequent in men (59.5% vs. 56.1%; p ¼ 0.003).
When best practices and protocolswere added to the
hierarchical linear regression that characterizes the
contribution of female gender to patient-specific
effective dose (i.e., adding protocols and best prac-
tices in addition to the covariates in the SimpleModel),
no significant difference remained in MPI effective
dose between women and men (Table 2, Comprehen-
sive Model; difference in dose 0.05 mSv; p ¼ 0.26).
GENDER INEQUALITY INDEX, HUMAN DEVELOPMENT
INDEX, AND PATIENT-LEVEL DOSE REDUCTION BEST
PRACTICES. We employed separate logistic regression
models to evaluate the contribution of GII, HDI, and
female gender to patient-level dose reduction best
practices and protocols. After adjusting for GII,
women were less likely than men to benefit from
camera-based dose reduction technology, more likely
to receive stress-only imaging, and less likely to
receive thallium. After adjustment for GII, there was
no statistically significant difference in the avoidance
of dual-isotope imaging depending on gender. The
impact of GII and HDI on the odds of a patient’s
receiving best practices was extremely small (Table 4).
DISCUSSION
In cardiology practice, men and women often have
different clinical presentations, prevalence of disease,
and risk profiles, which may lead to the underesti-
mation of CAD in women. It is important for an
investigation strategy to be sensitive to such differ-
ences. In terms of nuclear cardiology, the implications
of these differences necessitate understanding the
current use of best practices between men and
women, to ensure that women benefit equally from
MPI without undue added risk. In this large, multi-
national clinical study, we explored gender differ-
ences in patient effective dose and laboratory best
practices for MPI across geographic regions. On thebasis of our analysis, we found that fewer women
underwent MPI than did men in all world regions;
however, there was no significant systematic associ-
ation between the proportion of women undergoing
MPI and societal gender inequality as quantified by
TABLE 4 Association of Female Gender, Gender Inequality Index, and Human Development Index on Best Practice and Protocol Use*
Odds Ratio (95% CI)
Unadjusted p Value
Odds Ratio (95% CI)
Adjusted for GII p Value
Odds Ratio (95% CI)
Adjusted for HDI p Value
Basic protocols
1-day SPECT 1.01 (0.92 to 1.12) 0.80 1.01 (0.91 to 1.11) 0.92 1.00 (0.91 to 1.10) 0.99
Multiday SPECT 0.96 (0.86 to 1.06) 0.39 0.96 (0.87 to 1.07) 0.48 0.98 (0.89 to 1.09) 0.76
PET 1.11 (0.92 to 1.33) 0.29 1.11 (0.92 to 1.34) 0.28 1.07 (0.89 to 1.29) 0.48
Best practices
Avoid dual isotope 1.51 (0.99 to 2.31) 0.05 1.41 (0.92 to 2.16) 0.11 1.33 (0.87 to 2.04) 0.19
Avoid stress thallium 1.45 (1.05 to 1.99) 0.02 1.42 (1.03 to 1.96) 0.03 1.34 (0.97 to 1.85) 0.08
Stress-only imaging 1.56 (1.35 to 1.81) <0.001 1.54 (1.33 to 1.78) <0.001 1.56 (1.35 to 1.81) <0.001
Camera-based dose
reduction technology
0.74 (0.67 to 0.81) <0.001 0.72 (0.65 to 0.79) <0.001 0.73 (0.66 to 0.80) <0.001
*Logistic regression models demonstrate the relationship between female gender and use of best practices that are interpretable on the patient level. For example, the odds
that camera-based dose reduction technology was used in a woman’s study were 0.74 of the odds for a man’s study. After adjustment for GII, the odds that camera-based dose
reduction technology was used in a woman’s study were 0.72 of the odds for a man’s study, a finding suggesting that a society’s gender inequality, at least as captured by the
GII, plays little role in the use of dose reduction technology. Best practices considered are those with patient-level interpretations.
GII ¼ Gender Inequality Index; HDI ¼ Human Development Index; other abbreviations as in Tables 2 and 3.
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382the GII. Nevertheless, in several countries women
constituted fewer than 35% of patients undergoing
MPI (Figure 1); identification of such underrepresen-
tation is a potential actionable finding that can spur
efforts to ensure appropriate referral of women for
MPI. In addition, women underwent MPI on average at
a slightly older age than did their male counterparts.
From a global perspective, the difference in mean
radiation effective dose between women and men
was very modest, and it was not significant after
adjustment for age, weight, and best practices and
protocols. It remains uncertain whether the observed
modestly lower radiation to women is by intent (i.e.,
implementation of practices to lower radiation to
women) or whether it is dictated by regional differ-
ences in resources, access to radiopharmaceuticals, or
use of radionuclide imaging within different, possibly
gender-related clinical contexts or for assessment of
CAD versus viability and differences in patient pop-
ulation. Increased use of stress-only protocols (21)
combined with lower use of thallium and dual-
isotope imaging in women likely contributed to this
overall lower effective radiation dose. Nevertheless,
in a few countries women had higher radiation doses
from MPI than did men (Figure 2); this should serve as
an actionable finding for such countries and labora-
tories. We found no statistically significant difference
in the use of PET in women compared with men
across the world, likely at least in part because of
limited access to PET scanners on the global market.
Personalizing MPI protocols on the basis of the
specific clinical question, the patient’s preference, and
patient-specific factors is important for the optimal
practice of nuclear cardiology (22,23). In terms of the
association between sex and gender differences on the
choice of MPI protocol, we found that women weremore likely than men to have stress-only imaging.
Because stress-only MPI is preferred when the pre-test
likelihood of CAD is low or intermediate and because
women often have a lower pre-test probability of CAD
and a less reliable exercise electrocardiogram than
men, it is not surprising that women were more likely
to have stress-only MPI for risk stratification.
Stress 201Tl and dual-isotope protocols were avoi-
ded in both men and women by the majority of the
laboratories studied. Further, women had signifi-
cantly fewer 201Tl and dual-isotope studies compared
with men. The decreased use of 201Tl in women could
have been related to several factors. Breast attenua-
tion artifact is often increased in women compared
with men, whereas diagnostic sensitivity is reduced in
persons with small hearts (24), a factor that is exacer-
bated by the poorer spatial resolution for a given
camera using 201Tl compared with technetium-99m
(99mTc). Higher radiation exposure from 201Tl
compared with 99mTc could also have contributed to
making 99mTc a more attractive imaging agent.
Further, given the higher incidence of previous
myocardial infarction in men undergoing MPI, men
may have been more likely to have had 201Tl MPI to
assess for myocardial viability compared with women,
who likely had MPI to diagnose CAD. In INCAPS, we
could not evaluate whether men received more 201Tl
imaging because of a higher need for viability evalu-
ation, or whether women receivedmore 99mTc imaging
out of concern for breast tissue attenuation and radi-
ation exposure. Even so, the differences in radiation
dose between men and women were very modest.
Interestingly, men were more likely to be assigned
camera-based dose reduction strategies than were
women. Even after excluding multiposition imaging,
which was more frequent in men compared with
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383women, the use of camera-based dose reduction
strategies of novel hardware, novel software, and
attenuation correction was still more common in men.
Because most of these novel camera-based technolo-
gies typically require more expensive equipment, it is
possible that more men were scanned in high-end
laboratories compared with women, although further
data would be needed to confirm this possibility.
Notably, even after accounting for gender inequality
in society and for human development by country,
women were still less likely than men to be assigned
camera-based dose reduction technology, but they
were more likely than men to benefit from stress-only
imaging. Another factor affecting these differences
could be the average 10-kg lower body weight in
women, which could lead to fewer attenuation arti-
facts and consequently improved image quality.
Nuclear cardiology tests are increasingly being used
globally for the evaluation of CAD. As such, we sought
to explore the gender-specific differences in imaging
practices related to human development status and
gender inequality in society. A recent study (25) re-
ported that CAD prevalence is positively correlated
with HDI in developing countries, thus reflecting the
growing epidemic of CAD in developing countries. In
contrast, HDI was negatively correlated with CAD
prevalence in developed countries, a finding reflecting
the declining trends of CAD in these countries.
A unique strength of INCAPS is the large number of
studies evaluated from different regions of the world.
To the best of our knowledge, INCAPS allows, for the
first time, a study of GII and HDI and their impact on
nuclear cardiology procedures in men and in women.
STUDY LIMITATIONS. Despite the large sample size
and the global applicability of the results, INCAPS has
certain limitations. Practice patterns in the labora-
tories that participated in INCAPS may not fully be
generalizable to practice patterns at the level of the
country. Gender differences in the choice of MPI pro-
tocol could reflect gender-specific attenuation arti-
facts (e.g., breast attenuation) or gender differences in
pre-test probability of CAD. For example, stress-only
MPI was more common in women, and women,
particularly those younger than 60 years of age, have a
lower pre-test probability of CAD than do men. Mea-
surement of administered activity is not standardized
among laboratories internationally, and most labora-
tories do not exclude residual activity remaining in the
syringe and tubing, which can vary among patients.
Nevertheless, there is no evidence suggesting or
reason to believe that residual activity depends on
gender. Effective dose, as defined by the International
Commission on Radiological Protection (26), does not
reflect patient-specific characteristics such as weight,anatomy, and biokinetics (27). We did not investigate
any possible social context or attributes that may have
influenced the slightly lower exposure in women (e.g.,
perception of women as patients). Imaging using a
reduced radiation dose must be balanced by high-
quality and diagnostic images to minimize layered
testing. The results of nuclear cardiology studies and
image quality information were not collected; there-
fore, we are unable to evaluate whether imaging using
a low radiation dose was associated with limitations in
image quality or diagnostic accuracy. We hope to
address these limitations in further research.
CONCLUSIONS
In theworldwide INCAPS, women underwentMPIwith
somewhat lower frequency thanmen, whereas women
and men received similar radiation doses when un-
dergoing MPI, with slightly lower doses in women in
part reflecting lower body weight. Our findings sug-
gest, reassuringly, that there does not seem to be a
large gender bias in radiation exposure from MPI
globally. There were some gender-based differences in
radiation-related “best practice” use, with a higher
proportion of women receiving stress-only imaging
but a higher proportion of men undergoing MPI using
camera-based dose reduction technology. Regional
differences in practice noted, such as a relatively small
proportion of MPI studies undertaken in women in
some countries, and higher average radiation doses to
women versus men in others, serve as potentially
actionable areas.
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PERSPECTIVES
COMPETENCYINPATIENTCAREANDPROCEDURAL
SKILLS: Nuclear cardiology imaging using a low radiation
dose is essential tomaximize the utility of the test. This study
explores gender differences in effective radiation dose from
nuclear cardiology studies worldwide. An understanding of
gender differences in best practices and radiation safety in
nuclear cardiology globally is vital so that disparities can be
addressed.
TRANSLATIONAL OUTLOOK: Additional studies are
needed to define the effects of low radiation dose from
nuclear cardiology procedures on image quality and diag-
nostic accuracy in women compared with men globally.
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